Prognostic benefit of immunosuppressive agents in primary Sjögren’s syndrome patients with hypergammaglobulinemia
ObjectiveTo elucidate the prognosis of patients with primary Sjögren’s syndrome (pSS) accompanied by hypergammaglobulinemia (HG), with a particular focus on the impact of various treatments.MethodsPatients were divided into the HG group and the non-HG group, based on the presence or absence of HG [s...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2026-03-01
|
| Edice: | Frontiers in Immunology |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1772604/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
